RELICTEC (RELICTEC) Fair Value & Analysis
IN · Market cap ₹385M
Fair value as of: Jul 5, 2026
From 1 valuation models · updated today
Share price −7.6% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹62.25 – ₹89.69 · fair‑value band ₹15.70 – ₹29.73 · the ₹68.83 price screens above the ₹23.78 fair value. As of Jul 5, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
RELICTEC (RELICTEC) currently trades at ₹68.83, while our model-based Fair Value estimate is ₹23.78 — implying the stock looks roughly 65.5% overvalued today. We read business quality at 33/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Trailing-twelve-month revenue stands at ₹33.2M. Revenue grew 58.9% year over year. It earns a return on equity of -65.4%. Fundamentals as of Jul 5, 2026
Our scenario range runs from ₹15.70 (bear case) to ₹29.73 (bull case); at ₹68.83, the current price sits above that range. The share trades about 27% below its 52-week high and 21% above its 52-week low, currently below its 200-day average.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
RELICTEC reported revenue of ₹26.7M in FY2026 versus ₹17.2M in FY2022, a compound +11.6%/yr. Reported net income was −₹53.7M in FY2026.
Is RELICTEC fairly valued? → Check now
Explore undervalued stocks
Frequently asked questions
Is RELICTEC (RELICTEC) undervalued?
What is the fair value of RELICTEC?
What is the quality score of RELICTEC?
What is the revenue of RELICTEC (RELICTEC)?
What is the net profit margin of RELICTEC?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.